Biotech China 2014
Drug Development Latin America
Philadelphia City Center

Philadelphia, Pennsylvania
http://www.clinicalops.com/lam
   Speakers
   --------

   N/A

   CHI’s and the BioPharma Strategy Series’ Second Annual Drug
   Development Latin America: Effectively Planning and Implementing
   Clinical Research and Trials will be held March 10-11, 2010 at the
   Crowne Plaza Philadelphia City Center in Philadelphia, PA. This year
   this gathering will be co-located with the Summit for Clinical Ops
   Executives ( SCOPE ), a four-day cluster of events taking place March
   8-11, 2010. CHI’s Drug Development Latin America will open with an
   inclusive short course on ‘Country and Site Feasibility and Selection
   for Global Clinical Trials’ and will be preceded immediately by its
   sister conference, the Third Annual Patient Recruitment in Clinical
   Trials conference. The globalization of R&D into emerging regions
   continues. Growing R&D spending in Asia, Latin America and CIS
   countries has been driven by many factors including the attractiveness
   of commercial markets there, more favorable economics including lower
   relative costs for greater speed, access to highly skilled
   professional labor and a large pool of patients, particularly
   treatment-naïve ones. Pharmaceutical and biotechnology companies are
   seeing rapid growth in the volume of their clinical research,
   development, and clinical trials activity in Latin America. At the
   same time, this region presents unique challenges that must be
   anticipated and managed. This conference is intended to cover the key
   issues, opportunities, and challenges of clinical research,
   development, and clinical trials in Latin America.

Schedule of Presentations:

Wednesday, March 10, 2010
Thursday, March 11, 2010
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.